ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.435
0.32%
US Dollar vs AUD
1.53095
-0.14%
Bitcoin
64,153.35
-0.51%
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Evaxion Biotech AS (EVAX)

  7. Evaxion Biotech AS (EVAX) News

EVAX Evaxion Biotech AS

4.12
0.00 (0.00%)
Pre Market
Last Updated: 18:19:05
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Evaxion Biotech AS EVAX NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 4.12 18:19:05
Open Price Low Price High Price Close Price Previous Close
4.12
more quote information »

Recent News

Date Time Source Heading
17/4/202422:00GLOBEEvaxion Announces Phase 2 Clinical Trial Update: First..
02/4/202422:00GLOBEEvaxion and Undisclosed Collaborator Announce Encouraging..
27/3/202422:30GLOBEEvaxion Announces Business Update and Full Year 2023..
19/3/202422:30GLOBEEvaxion Hosts R&D Day and Unveils the Broad Potential of Its..
29/2/202423:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202423:30GLOBEEvaxion to Host R&D Day on March 19, 2024, Highlighting its..
20/2/202423:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/2/202423:30GLOBEEvaxion Announces Successful Completion of the Initial..
08/2/202408:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/2/202400:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/2/202400:30GLOBEEvaxion Regains Compliance with Nasdaq Minimum Bid Price..
07/2/202400:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/2/202400:30GLOBEEvaxion Announces Closing of $15 Million Public Offering
06/2/202401:09EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
05/2/202423:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/2/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
02/2/202401:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/2/202401:20GLOBEEvaxion Biotech Announces Pricing of $15 Million Public..
01/2/202409:10EDGAR2Form F-1/A - Registration statement for certain foreign..
01/2/202401:26EDGAR2Form F-1/A - Registration statement for certain foreign..
31/1/202407:16EDGAR2Form F-1/A - Registration statement for certain foreign..
27/1/202408:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/1/202406:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/1/202400:30GLOBEEvaxion to Develop Tailored Novel Cancer Vaccines Based upon..
23/1/202408:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202408:30GLOBEEvaxion Announces Completion of ADS Ratio Change
13/1/202409:17EDGAR2Form F-1 - Registration statement for certain foreign..
13/1/202401:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/1/202400:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202400:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202400:30GLOBEEvaxion Announces Plan to Implement ADS Ratio Change
22/12/202308:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/12/202308:30GLOBEEvaxion Biotech Announces Closing of Private Placement
20/12/202308:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202308:15GLOBEEvaxion Announces Business Update and Third Quarter 2023..
20/12/202301:25GLOBEEvaxion Biotech Announces Private Placement Financing
20/12/202300:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/12/202308:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202300:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202300:27GLOBEEvaxion to Unveil Potentially Groundbreaking AI-Immunology™..
18/11/202301:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202300:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202300:00GLOBEEvaxion Presents Proof-of-Principle for Its Unique AI Model..
07/11/202302:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202302:12GLOBEEvaxion Shares Latest EVX-01 Phase 2 Clinical Data in..
01/11/202302:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202302:14GLOBEEvaxion Announces Encouraging Initial Phase 2 Clinical Data..
26/10/202323:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202323:30GLOBENew and Exciting Clinical Data on Evaxion’s..
14/10/202307:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Your Recent History

NASDAQ
EVAX
Evaxion Biotech AS
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved